Advertisement
Canada markets open in 9 hours 15 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7260
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    84.85
    +2.12 (+2.56%)
     

  • Bitcoin CAD

    85,862.99
    +428.67 (+0.50%)
     

  • CMC Crypto 200

    1,277.87
    +392.33 (+42.69%)
     

  • GOLD FUTURES

    2,402.20
    +4.20 (+0.18%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     

  • NASDAQ futures

    17,337.75
    -209.50 (-1.19%)
     

  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     

  • FTSE

    7,877.05
    +29.06 (+0.37%)
     

  • NIKKEI 225

    37,169.04
    -910.66 (-2.39%)
     

  • CAD/EUR

    0.6821
    0.0000 (0.00%)
     

Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know

Zacks Equity Research
·2 min read

In the latest trading session, Canopy Growth Corporation (CGC) closed at $15.76, marking a +0.13% move from the previous day. This move lagged the S&P 500's daily gain of 0.9%. Meanwhile, the Dow gained 0.56%, and the Nasdaq, a tech-heavy index, added 1.13%.

Prior to today's trading, shares of the company had gained 9.76% over the past month. This has lagged the Medical sector's gain of 14.19% and the S&P 500's gain of 14.3% in that time.

CGC will be looking to display strength as it nears its next earnings release. In that report, analysts expect CGC to post earnings of -$0.27 per share. This would mark year-over-year growth of 59.7%. Our most recent consensus estimate is calling for quarterly revenue of $97.14 million, up 37.33% from the year-ago period.

Any recent changes to analyst estimates for CGC should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

ADVERTISEMENT

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.17% higher. CGC currently has a Zacks Rank of #2 (Buy).

The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 33, which puts it in the top 13% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.